Literature DB >> 29537120

Development of algorithms for identifying fatal cardiovascular disease in Medicare claims.

Fenglong Xie1,2, Lisandro D Colantonio1, Jeffrey R Curtis1,2, Meredith L Kilgore3, Emily B Levitan1, Keri L Monda4, Monika M Safford5, Ben Taylor4, Mark Woodward6,7,8, Paul Muntner1.   

Abstract

BACKGROUND: Cause of death is often not available in administrative claims data.
OBJECTIVE: To develop claims-based algorithms to identify deaths due to fatal cardiovascular disease (CVD; ie, fatal coronary heart disease [CHD] or stroke), CHD, and stroke.
METHODS: Reasons for Geographic and Racial Differences in Stroke (REGARDS) study data were linked with Medicare claims to develop the algorithms. Events adjudicated by REGARDS study investigators were used as the gold standard. Stepwise selection was used to choose predictors from Medicare data for inclusion in the algorithms. C-index, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were used to assess algorithm performance. Net reclassification index (NRI) was used to compare the algorithms with an approach of classifying all deaths within 28 days following hospitalization for myocardial infarction and stroke to be fatal CVD.
RESULTS: Data from 2,685 REGARDS participants with linkage to Medicare, who died between 2003 and 2013, were analyzed. The C-index for discriminating fatal CVD from other causes of death was 0.87. Using a cut-point that provided the closest observed-to-predicted number of fatal CVD events, the sensitivity was 0.64, specificity 0.90, PPV 0.65, and NPV 0.90. The algorithms resulted in positive NRIs compared with using deaths within 28 days following hospitalization for myocardial infarction and stroke. Claims-based algorithms for discriminating fatal CHD and fatal stroke performed similarly to fatal CVD.
CONCLUSION: The claims-based algorithms developed to discriminate fatal CVD events from other causes of death performed better than the method of using hospital discharge diagnosis codes.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Medicare claims; algorithm; fatal cardiovascular disease; pharmacoepidemiology

Mesh:

Year:  2018        PMID: 29537120      PMCID: PMC7050209          DOI: 10.1002/pds.4421

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  22 in total

1.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.

Authors:  Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

2.  Logistic regression: a brief primer.

Authors:  Jill C Stoltzfus
Journal:  Acad Emerg Med       Date:  2011-10       Impact factor: 3.451

3.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

4.  Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  Jewell H Halanych; Faisal Shuaib; Gaurav Parmar; Rajasekhar Tanikella; Virginia J Howard; David L Roth; Ronald J Prineas; Monika M Safford
Journal:  Am J Epidemiol       Date:  2011-05-03       Impact factor: 4.897

Review 5.  Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.

Authors:  Maarten J G Leening; Moniek M Vedder; Jacqueline C M Witteman; Michael J Pencina; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2014-01-21       Impact factor: 25.391

6.  Distinct age and self-rated health crossover mortality effects for African Americans: Evidence from a national cohort study.

Authors:  David L Roth; Kimberly A Skarupski; Deidra C Crews; Virginia J Howard; Julie L Locher
Journal:  Soc Sci Med       Date:  2016-03-16       Impact factor: 4.634

7.  Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.

Authors:  David J Graham; Rita Ouellet-Hellstrom; Thomas E MaCurdy; Farzana Ali; Christopher Sholley; Christopher Worrall; Jeffrey A Kelman
Journal:  JAMA       Date:  2010-06-28       Impact factor: 56.272

8.  Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease.

Authors:  Elsayed Z Soliman; Ronald J Prineas; L Douglas Case; Gregory Russell; Wayne Rosamond; Thomas Rea; Nona Sotoodehnia; Wendy S Post; David Siscovick; Bruce M Psaty; Gregory L Burke
Journal:  Heart       Date:  2011-07-20       Impact factor: 5.994

9.  Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.

Authors:  Jie Zhang; Fenglong Xie; Huifeng Yun; Lang Chen; Paul Muntner; Emily B Levitan; Monika M Safford; Shia T Kent; Mark T Osterman; James D Lewis; Kenneth Saag; Jasvinder A Singh; Jeffrey R Curtis
Journal:  Ann Rheum Dis       Date:  2016-01-20       Impact factor: 19.103

10.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

View more
  3 in total

1.  Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.

Authors:  Jeffrey R Curtis; Fenglong Xie; Cynthia S Crowson; Eric H Sasso; Elena Hitraya; Cheryl L Chin; Richard D Bamford; Rotem Ben-Shachar; Alexander Gutin; Darl D Flake; Brent Mabey; Jerry S Lanchbury
Journal:  Arthritis Res Ther       Date:  2020-12-04       Impact factor: 5.156

2.  Clinical and economic impact of changing reimbursement criteria for statin treatment among patients with type 2 diabetes mellitus in South Korea.

Authors:  Siin Kim; Kyungseon Choi; Ji-Yool Kim; Hae Sun Suh
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

3.  Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study.

Authors:  F Cosman; C Cooper; Y Wang; B Mitlak; S Varughese; S A Williams
Journal:  Osteoporos Int       Date:  2022-05-07       Impact factor: 5.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.